Quegen Biotech Overview

  • Year Founded
  • 2006

Year Founded

  • Status
  • Out of Business

  • Employees
  • 14

Employees

  • Latest Deal Type
  • Out of Business

Quegen Biotech General Information

Description

Operator of a biotech company intended to produce cosmetic raw materials. The company utilizes biological resources to produce raw materials, providing clients with functional cosmetics as per their needs.

Contact Information

Website
www.quegen.com
Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • 54, Mayu-ro 92beon-gil
  • Siheung, Gyeonggi
  • South Korea
Primary Industry
Personal Products
Vertical(s)
Corporate Office
  • 54, Mayu-ro 92beon-gil
  • Siheung, Gyeonggi
  • South Korea

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Quegen Biotech Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Out of Business 10-Oct-2025 Completed Out of Business
2. Later Stage VC (Series B) 18-Mar-2019 Completed Generating Revenue
1. Later Stage VC (Series B) 23-Aug-2016 Completed Generating Revenue
To view Quegen Biotech’s complete valuation and funding history, request access »

Quegen Biotech Patents

Quegen Biotech Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2020246817-A1 Gut flora-improving composition comprising beta-glucan and use thereof Inactive 07-Jun-2019
WO-2020085735-A1 Method for preparing bioconversion products of asparagus cochinchinensis and soybean embryos by means of liquid culturing of basidiomycetes mycelium, and use thereof Inactive 26-Oct-2018
JP-2021531244-A A pharmaceutical composition for wound healing or skin activation containing beta-glucan, glycitin and 4', 6,7-trimethoxyisoflavone. Pending 22-Jun-2018
US-20210260096-A1 Pharmaceutical composition for treating wound or activating skin, containing beta-glucan, glycitin, and 4',6,7-trimethoxyisoflavone Inactive 22-Jun-2018
WO-2019245275-A1 Composition, comprising β-glucan-peptide complex and antibiotic, for prevention, alleviation, or treatment of inflammatory disease Inactive 20-Jun-2018 A23L33/21
To view Quegen Biotech’s complete patent history, request access »

Quegen Biotech Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Quegen Biotech FAQs

  • When was Quegen Biotech founded?

    Quegen Biotech was founded in 2006.

  • Where is Quegen Biotech headquartered?

    Quegen Biotech is headquartered in Siheung, South Korea.

  • What is the size of Quegen Biotech?

    Quegen Biotech has 14 total employees.

  • What industry is Quegen Biotech in?

    Quegen Biotech’s primary industry is Personal Products.

  • Is Quegen Biotech a private or public company?

    Quegen Biotech is a Private company.

  • What is Quegen Biotech’s current revenue?

    The current revenue for Quegen Biotech is .

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process